- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/82 - AmidesImides in position 3
Patent holdings for IPC class C07D 213/82
Total number of patents in this class: 1071
10-year publication summary
|
101
|
75
|
75
|
64
|
76
|
56
|
67
|
69
|
53
|
22
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4811 |
25 |
| Takeda Pharmaceutical Company Limited | 2718 |
24 |
| F. Hoffmann-La Roche AG | 7837 |
19 |
| Vertex Pharmaceuticals Incorporated | 1597 |
19 |
| Novartis AG | 10327 |
17 |
| Boehringer Ingelheim International GmbH | 4509 |
17 |
| Amgen Inc. | 4357 |
17 |
| Syngenta Participations AG | 1581 |
16 |
| The Johns Hopkins University | 5825 |
16 |
| BASF SE | 21150 |
14 |
| Syngenta Crop Protection AG | 6513 |
14 |
| AstraZeneca AB | 2832 |
10 |
| Bayer Cropscience AG | 1885 |
10 |
| Janssen Pharmaceutica N.V. | 3231 |
9 |
| Sumitomo Chemical Company, Limited | 9055 |
9 |
| Gilead Sciences, Inc. | 2189 |
9 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 856 |
9 |
| Mitsui Chemicals Crop & Life Solutions,Inc. | 172 |
9 |
| Genentech, Inc. | 4076 |
8 |
| The General Hospital Corporation | 4827 |
8 |
| Other owners | 792 |